FDA/CDC
FDA/CDC
Stryker issues voluntary field action for Lifepak 15 defibrillators
The field action includes 13,003 devices.
News
FDA labeling templates smooth way for OTC naloxone
The templates aim to ease the submission process for manufacturers.
FDA/CDC
Torrent Pharmaceuticals expands losartan recall
Ten more lots recalled.
FDA/CDC
Sickle cell infusion gains FDA breakthrough designation
The investigational therapy is aimed at preventing vasoocclusive crises.
FDA/CDC
Atezolizumab combination regimen approved for advanced non-squamous NSCLC
The FDA approved checkpoint inhibitor atezolizumab for the treatment of metastatic non-squamous NSCLC with no EGFR or ALK genomic tumor...
FDA/CDC
Heart disease remains the leading cause of death in U.S.
Stroke, diabetes, and Alzheimer’s deaths are up in 2017.
FDA/CDC
U.S. life expectancy down; drug overdose, suicide up sharply
Adults in their working years – especially men and those in rural areas – are hardest hit.
FDA/CDC
Teva recalls valsartan-containing combo pills
Teva has now recalled all of its unexpired valsartan-containing products from the U.S. market.
FDA/CDC
FDA approves sufentanil for adults with acute pain
The opioid is to used for only adult patients in settings that are closely controlled.
FDA/CDC
FDA panels vote no on opioid-containing drug for MDD
The advisory panels voted 21-2 against recommending the combo drug as an add-on for refractory depression.